High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases - Top-Institutions - MDSpire

High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases

  • By

  • Marit A. Martiniussen

  • Marie B. Bergan

  • Merete U. Kristiansen

  • Nataliia Moshina

  • Anne Sofie F. Larsen

  • Marthe Larsen

  • Fredrik A. Dahl

  • Solveig Hofvind

  • May 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    BreastScreen Norway
    BreastScreen Norway

    Oslo, Norway

    Key Differentiators

    • Radiology
    • Public Health

  • #2

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Radiology
    • Medical Education

  • #3

    Norwegian Institute of Public Health
    Norwegian Institute of Public Health

    Oslo, Norway

    Key Differentiators

    • Public Health
    • Epidemiology

  • #4

    University Hospital RWTH Aachen
    University Hospital RWTH Aachen

    Aachen, Germany

    Key Differentiators

    • Radiology
    • Diagnostic Imaging

  • #5

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Radiology
    • Healthcare

Original Source(s)

High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases

  • by Marit A. Martiniussen, Marie B. Bergan, Merete U. Kristiansen, Nataliia Moshina, Anne Sofie F. Larsen, Marthe Larsen, Fredrik A. Dahl, Solveig Hofvind

  • May 6, 2026

Related Content

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • by

  • May 25, 2026

  • 9 min